Researchers Studying Model to Learn Why Certain Cancers Become Resistant to Drugs

Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news109597260.html">Researchers Studying Model to Learn Why Certain Cancers Become Resistant to Drugs</a></p> <p>Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible. </p>